Log In
Register
Facebook icon
Instagram icon
Twitter X icon
LinkedIn icon
Research
Injectables
Devices
Skin Care
Injectables
Injectables
Dermal Fillers Market Estimated To Reach $34.6 Billion by 2035
Rising demand for non-invasive procedures with natural results is driving the market.
Featured
News
Galderma Announces FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission
According to the trial results, RelabotulinumtoxinA delivered sustained results for six months for both frown lines and crow’s feet.
Sponsored
The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics
At ASDS, Allergan Aesthetics convened experts to explore the future of hyaluronic acid fillers—dispelling myths, sharing data and emphasizing education for subtle, natural-looking results.
Read the latest issue
January/February 2026
Top Headlines
News
Galderma Launches ‘Wake Up to Restylane’ Global Campaign
Home
Researchers Develop Injectable Skin-Cell Paste to Improve Breast Reconstruction Outcomes
Home
The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics
Sponsored
The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics
Latest
News
Hybrid and Non-Absorbable Fillers Drive Strong Growth in Global Aesthetic Fillers Market
A new market report reveals surprising shifts in consumer demand, regional dynamics and breakthrough filler technologies that are reshaping the multi-billion-dollar aesthetic fillers industry.
Home
TrumpRX to Offer Discounted GLP-1 Drugs—What Aesthetic Providers Should Know About Access, Pricing, Patient Retention
The TrumpRX platform promises lower-cost access to GLP-1 medications, but experts say proper monitoring and holistic care remain key to safe, sustainable results—raising questions about how this shift could reshape the booming medspa and wellness industry.
Sponsored
The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics
At ASDS, Allergan Aesthetics convened experts to explore the future of hyaluronic acid fillers—dispelling myths, sharing data and emphasizing education for subtle, natural-looking results.
Home
New Study Reveals Patients Are Lacking Awareness of Neurotoxin Ingredients
A new study reveals patients aren't nearly as ingredient-savvy when it comes to neurotoxins—despite key differences in their formulas that could impact results.
Home
Cultural Identity Is Taking Center Stage in Rhinoplasty—and Surgeons Are Listening
As social media challenges Eurocentric beauty norms, a new wave of rhinoplasty is embracing ethnic identity over erasure—reshaping not just noses, but the definition of beauty itself.
Home
Baby Botox in Your 20s and 30s: Preventive Power or Cosmetic Overkill?
As Baby Botox gains popularity among people in their 20s and 30s, experts weigh in on its potential benefits, risks and long-term impact—could early prevention be the key to aging well?
Home
Are Facials Just Pampering? Debunking the Myths and Exploring Their Clinical Impact
Discover common myths about facials and its functional role in clinical aesthetics—showing how facials prepare the skin and support recovery beyond the widespread belief that they're merely relaxing.
Home
Neurotoxins Surge, Hyaluronic Fillers Slip: GLP-1 and Skincare Usher in a New Chapter
Guidepoint Qsight’s report shows a rise in GLP-1 medications being paired with body contouring and a shift in filler use—biostimulatory fillers gain popularity while HA fillers decline. Skincare is also emerging as a core part of treatment plans, adding revenue and reinforcing practices' roles in long-term care.
Companies
Eirion Therapeutics Unveils Promising AI-09 Liquid Botulinum Trial Results at 2025 SID Meeting
At the 2025 annual meeting of the Society for Investigative Dermatology that took place in San Diego, California on May 7-10, Eirion Therapeutics Inc., a biopharmaceutical company, presented results from recent clinical trials evaluating its AI-09.
Treatments
Galderma's Relfydess Shows Promising Results in Treating Frown Lines and Crow's Feet in Phase IIIb Trial, Presented at IMCAS
Within the liquid neuromodulator, Galderma uses precipitation-free extraction and activity-preserving refined liquid (Pearl) technology designed to preserve molecule integrity to deliver a highly active, innovative, complex-free molecule to frown lines.
Treatments
What is "Ozempic Face" & Why Does it Occur? Separating Fact From Fiction
We're diving into the "Ozempic Face" phenomenon to examine Ozempic's various effects on facial skin, what causes these side effects and separating the myths from the truth about its impact on facial aesthetics.
Practice Management
Expert Insights: Trends & Innovations in Mid-Face Rejuvenation
A recent Kline report revealed that the mid-face is the primary focal point for non-invasive aesthetic treatments. These insights from industry experts can help you stay on top of the latest trends and innovations in mid-face rejuvenation.